ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Mexico » Geriatric Medicine

Top Geriatric Medicine Prescribers in New Mexico

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JESUS DURAN M.D.

Geriatric Medicine

22,185

$1.43M

1183
1051 are 65+

2%
patients receiving schedule two controlled substances

Avg: 9%

7%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 21%

$64
Average prescription price

Avg: $62

JILL RHYMES M.D.

Geriatric Medicine

11,732

$789K

732
672 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

11%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 21%

$67
Average prescription price

Avg: $62

SAMUEL GOLDMAN MD

Geriatric Medicine

6,589

$294K

623
566 are 65+

26%
patients receiving schedule two controlled substances

Avg: 9%

22%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 21%

$45
Average prescription price

Avg: $62

EDWARD KOMPARE M.D.

Geriatric Medicine

5,957

$470K

124
114 are 65+

10%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 21%

$79
Average prescription price

Avg: $62

DAVID SCRASE MD

Geriatric Medicine

3,821

$255K

392
365 are 65+

6%
patients receiving schedule two controlled substances

Avg: 9%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 21%

$67
Average prescription price

Avg: $62

MAHMOOD ZAMANIAN MD

Geriatric Medicine

3,425

$173K

157
136 are 65+

17%
patients receiving schedule two controlled substances

Avg: 9%

15%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 21%

$51
Average prescription price

Avg: $62

DAVID HEMPHILL MD

Geriatric Medicine

3,239

$167K

277
273 are 65+

12%
patients receiving schedule two controlled substances

Avg: 9%

10%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 21%

$51
Average prescription price

Avg: $62

KIRSTEN SILVEY M.D.

Geriatric Medicine

2,833

$167K

316
304 are 65+

3%
patients receiving schedule two controlled substances

Avg: 9%

6%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 21%

$59
Average prescription price

Avg: $62

DEVON NEALE M.D.

Geriatric Medicine

2,743

$162K

183
180 are 65+

11%
patients receiving schedule two controlled substances

Avg: 9%

11%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 21%

$59
Average prescription price

Avg: $62

FRANCISCO TORRES MD

Geriatric Medicine

2,219

$98.8K

96
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

17%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 21%

$45
Average prescription price

Avg: $62

LAKSHMI GANGA MD

Geriatric Medicine

1,177

$68.6K

107
100 are 65+

13%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 21%

$58
Average prescription price

Avg: $62

MARY MCGUIGGIN MD

Geriatric Medicine

1,168

$58.7K

81
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 9%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 21%

$50
Average prescription price

Avg: $62

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank